264 related articles for article (PubMed ID: 33649839)
1. Histone deacetylase inhibitor givinostat alleviates liver fibrosis by regulating hepatic stellate cell activation.
Huang HM; Zhou XR; Liu YJ; Fan SJ; Liao LP; Huang J; Shi CC; Yu L; Pen JJ; Luo C; Zhang YY; Li GM
Mol Med Rep; 2021 May; 23(5):. PubMed ID: 33649839
[TBL] [Abstract][Full Text] [Related]
2. Givinostat inhibition of hepatic stellate cell proliferation and protein acetylation.
Wang YG; Xu L; Wang T; Wei J; Meng WY; Wang N; Shi M
World J Gastroenterol; 2015 Jul; 21(27):8326-39. PubMed ID: 26217084
[TBL] [Abstract][Full Text] [Related]
3. A new histone deacetylase inhibitor improves liver fibrosis in BDL rats through suppression of hepatic stellate cells.
Park KC; Park JH; Jeon JY; Kim SY; Kim JM; Lim CY; Lee TH; Kim HK; Lee HG; Kim SM; Kwon HJ; Suh JS; Kim SW; Choi SH
Br J Pharmacol; 2014 Nov; 171(21):4820-30. PubMed ID: 24467283
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-17-5p-activated Wnt/β-catenin pathway contributes to the progression of liver fibrosis.
Yu F; Lu Z; Huang K; Wang X; Xu Z; Chen B; Dong P; Zheng J
Oncotarget; 2016 Jan; 7(1):81-93. PubMed ID: 26637809
[TBL] [Abstract][Full Text] [Related]
5. Pigment epithelium-derived factor 34-mer peptide prevents liver fibrosis and hepatic stellate cell activation through down-regulation of the PDGF receptor.
Tsai TH; Shih SC; Ho TC; Ma HI; Liu MY; Chen SL; Tsao YP
PLoS One; 2014; 9(4):e95443. PubMed ID: 24763086
[TBL] [Abstract][Full Text] [Related]
6. Dihydroartemisinin counteracts fibrotic portal hypertension via farnesoid X receptor-dependent inhibition of hepatic stellate cell contraction.
Xu W; Lu C; Zhang F; Shao J; Yao S; Zheng S
FEBS J; 2017 Jan; 284(1):114-133. PubMed ID: 27896916
[TBL] [Abstract][Full Text] [Related]
7. Blockade of YAP alleviates hepatic fibrosis through accelerating apoptosis and reversion of activated hepatic stellate cells.
Yu HX; Yao Y; Bu FT; Chen Y; Wu YT; Yang Y; Chen X; Zhu Y; Wang Q; Pan XY; Meng XM; Huang C; Li J
Mol Immunol; 2019 Mar; 107():29-40. PubMed ID: 30639476
[TBL] [Abstract][Full Text] [Related]
8. 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) increases necroinflammation and hepatic stellate cell activation but does not exacerbate experimental liver fibrosis in mice.
Lamb CL; Cholico GN; Pu X; Hagler GD; Cornell KA; Mitchell KA
Toxicol Appl Pharmacol; 2016 Nov; 311():42-51. PubMed ID: 27693115
[TBL] [Abstract][Full Text] [Related]
9. Thymosin β4 suppresses CCl
Li H; Li Q; Zhang X; Zheng X; Zhang Q; Hao Z
J Gene Med; 2018 Sep; 20(9):e3043. PubMed ID: 29972714
[TBL] [Abstract][Full Text] [Related]
10. Deficiency in augmenter of liver regeneration accelerates liver fibrosis by promoting migration of hepatic stellate cell.
Ai WL; Dong LY; Wang J; Li ZW; Wang X; Gao J; Wu Y; An W
Biochim Biophys Acta Mol Basis Dis; 2018 Nov; 1864(11):3780-3791. PubMed ID: 30251695
[TBL] [Abstract][Full Text] [Related]
11. Icaritin induces cell death in activated hepatic stellate cells through mitochondrial activated apoptosis and ameliorates the development of liver fibrosis in rats.
Li J; Liu P; Zhang R; Cao L; Qian H; Liao J; Xu W; Wu M; Yin Z
J Ethnopharmacol; 2011 Sep; 137(1):714-23. PubMed ID: 21726622
[TBL] [Abstract][Full Text] [Related]
12. Mistletoe alkaloid fractions alleviates carbon tetrachloride-induced liver fibrosis through inhibition of hepatic stellate cell activation via TGF-β/Smad interference.
Jiang Y; Wang C; Li YY; Wang XC; An JD; Wang YJ; Wang XJ
J Ethnopharmacol; 2014 Dec; 158 Pt A():230-8. PubMed ID: 25456431
[TBL] [Abstract][Full Text] [Related]
13. Heparin-binding epidermal growth factor-like growth factor suppresses experimental liver fibrosis in mice.
Huang G; Besner GE; Brigstock DR
Lab Invest; 2012 May; 92(5):703-12. PubMed ID: 22330337
[TBL] [Abstract][Full Text] [Related]
14. Selective inhibition of activated stellate cells and protection from carbon tetrachloride-induced liver injury in rats by a new PPARgamma agonist KR62776.
Bae MA; Rhee SD; Jung WH; Ahn JH; Song BJ; Cheon HG
Arch Pharm Res; 2010 Mar; 33(3):433-42. PubMed ID: 20361309
[TBL] [Abstract][Full Text] [Related]
15. Physalin D attenuates hepatic stellate cell activation and liver fibrosis by blocking TGF-β/Smad and YAP signaling.
Xiang D; Zou J; Zhu X; Chen X; Luo J; Kong L; Zhang H
Phytomedicine; 2020 Nov; 78():153294. PubMed ID: 32771890
[TBL] [Abstract][Full Text] [Related]
16. Sauchinone attenuates liver fibrosis and hepatic stellate cell activation through TGF-β/Smad signaling pathway.
Lee JH; Jang EJ; Seo HL; Ku SK; Lee JR; Shin SS; Park SD; Kim SC; Kim YW
Chem Biol Interact; 2014 Dec; 224():58-67. PubMed ID: 25451574
[TBL] [Abstract][Full Text] [Related]
17. Metformin attenuates motility, contraction, and fibrogenic response of hepatic stellate cells
Li Z; Ding Q; Ling LP; Wu Y; Meng DX; Li X; Zhang CQ
World J Gastroenterol; 2018 Feb; 24(7):819-832. PubMed ID: 29467552
[TBL] [Abstract][Full Text] [Related]
18. Class II HDAC inhibition hampers hepatic stellate cell activation by induction of microRNA-29.
Mannaerts I; Eysackers N; Onyema OO; Van Beneden K; Valente S; Mai A; Odenthal M; van Grunsven LA
PLoS One; 2013; 8(1):e55786. PubMed ID: 23383282
[TBL] [Abstract][Full Text] [Related]
19. EZH2-mediated repression of Dkk1 promotes hepatic stellate cell activation and hepatic fibrosis.
Yang Y; Chen XX; Li WX; Wu XQ; Huang C; Xie J; Zhao YX; Meng XM; Li J
J Cell Mol Med; 2017 Oct; 21(10):2317-2328. PubMed ID: 28332284
[TBL] [Abstract][Full Text] [Related]
20. A Proof-of-Concept for Epigenetic Therapy of Tissue Fibrosis: Inhibition of Liver Fibrosis Progression by 3-Deazaneplanocin A.
Zeybel M; Luli S; Sabater L; Hardy T; Oakley F; Leslie J; Page A; Moran Salvador E; Sharkey V; Tsukamoto H; Chu DCK; Singh US; Ponzoni M; Perri P; Di Paolo D; Mendivil EJ; Mann J; Mann DA
Mol Ther; 2017 Jan; 25(1):218-231. PubMed ID: 28129116
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
